In Brief: Allergan
This article was originally published in The Tan Sheet
Executive Summary
Allergan: Merger discussions with Pharmacia & Upjohn "have been terminated," Allergan announces May 13. Irvine, Calif.-based Allergan reports that "the discussions involved a possible stock-for-stock merger with pooling of interest accounting treatment." However, Allergan notes, "it has now been determined that pooling treatment for such a transaction is not feasible." According to the Wall Street Journal, the stock swap transaction was not feasible for AB Volvo, a major shareholder in Pharmacia & Upjohn...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning